AUSTRALIA: Call to Expand Needle-Exchange Programs

Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.

AUSTRALIA: Call to Expand Needle-Exchange Programs

Australian Associated Press (10.22.09) - Friday, October 23, 2009
Danny Rose

Australia's liberal needle-exchange program over the past 10 years has helped to prevent 32,000 new HIV infections and almost 100,000 new cases of hepatitis C, says a new report from the National Center in HIV Epidemiology and Clinical Research (NCHECR).

"This study provides strong evidence to suggest that increased spending should be invested in expanding needle and syringe programs," Associate Professor David Wilson of NCHECR said in a statement. "Not only would it significantly reduce health burdens but it will ultimately save Australian taxpayers substantial amounts of money."

The existing program has saved taxpayers $1.3 billion (US $1.2 billion) in health outlays, the report says. The program cost $243 million (US $225 million) during that time.

Australia distributes 31 million clean needles and syringes every year through almost 1,000 distribution points such as clinics, pharmacies, and vending machines. The number of needles and syringes has increased steadily from 27 million at the start of the program.

Even with the program's growth, health officials estimate that half of drug injections are done with unclean needles and syringes. The report calls for increasing the availability of sterile equipment by 50 percent - a move it says would further reduce new HIV cases by 37 percent and new hepatitis C cases by 23 percent over the next 10 years.

Hepatitis Australia, an advocacy group, endorsed the expansion of the program.

"[T]he reality is people who inject drugs are unlikely to use another's person's injecting equipment if they have convenient access to sterile [alternatives]," Vice President Stuart Loveday said.
091023
AD091825

Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.